Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Sandra Calvin > Profile

Sandra Calvin

Affiliations

  • Svp, Chief Accounting Officer at Travere Therapeutics Inc. (TVTX), 2025-02-13
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
Travere Therapeutics Inc.
 TVTX $25.00 9,244 54,410 2025-02-11 Filing
Travere Therapeutics Inc.
 TVTX $25.00 15,000 63,654 2025-02-11 Filing
Travere Therapeutics Inc.
 TVTX $25.00 10,000 63,654 2025-02-11 Filing
Travere Therapeutics Inc.
 TVTX $25.00 10,000 63,654 2025-02-11 Filing
Travere Therapeutics Inc.
 TVTX $25.00 10,000 63,654 2025-02-11 Filing